On December 6 Carlsquare Equity Research will be hosting the 2023 edition of our annual Investor day with a focus on Life Science. Leading and exciting companies will be presenting themselves and host Q&A’s. Questions from the audience are encouraged.

There are still seats available but the number is limited.

For more information and to reserve your seat

Livestream

Details
Date: December 6
Location: Stockholm, Kungsgatan 33 (Infront Direkt Studios), 2F
Digital: Yes, livestream on YouTube

Participating companies and schedule
09:00 AM Nosa Plugs
09:30 AM Hansa Biopharma
10:00 AM Kancera
10:30 AM Prolight Diagnostics
11:00 AM Bentley Endovascular Group
11:30 AM Cantargia
12:00 AM-01:00 PM Lunch break (free wrap)
01:00 PM CombiGene
01:30 PM Biosergen
02:00 PM Gubra
02:30 PM Medivir
03:00 PM Biovica International

About Carlsquare

Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more

Contact
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20

Contacts

MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
 
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59

Attachments

Carlsquare Equity Research is hosting an Investor day with a focus on Life science